Works matching IS 15233790 AND DT 2021 AND VI 23 AND IP 12
Results: 14
The Role and Impact of Minimal Residual Disease in NSCLC.
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11912-021-01131-w
- By:
- Publication type:
- Article
Perioperative NSAIDs and Long-Term Outcomes After cancer Surgery: a Systematic Review and Meta-analysis.
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11912-021-01133-8
- By:
- Publication type:
- Article
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11912-021-01140-9
- By:
- Publication type:
- Article
Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients.
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11912-021-01134-7
- By:
- Publication type:
- Article
Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities.
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11912-021-01138-3
- By:
- Publication type:
- Article
New Directions in Imaging Neuroendocrine Neoplasms.
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11912-021-01139-2
- By:
- Publication type:
- Article
Is Myelodysplasia a Consequence of Normal Aging?
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11912-021-01136-5
- By:
- Publication type:
- Article
Circulating Tumour DNA and Colorectal Cancer: the Next Revolutionary Biomarker?
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11912-021-01137-4
- By:
- Publication type:
- Article
Cancer-Related Fatigue—Is There a Role for Complementary and Integrative Medicine?
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11912-021-01135-6
- By:
- Publication type:
- Article
A New Generation of Vaccines in the Age of Immunotherapy.
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11912-021-01130-x
- By:
- Publication type:
- Article
New Treatments for Recurrent Uterine Cancer.
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11912-021-01129-4
- By:
- Publication type:
- Article
Treatment Perspectives for Ovarian Cancer in Europe and the United States: Initial Therapy and Platinum-Sensitive Recurrence after PARP Inhibitors or Bevacizumab Therapy.
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11912-021-01128-5
- By:
- Publication type:
- Article
Current Role of Functional Imaging in the Management of Lymphoma.
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11912-021-01127-6
- By:
- Publication type:
- Article
Early Progressing Follicular Lymphoma.
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11912-021-01126-7
- By:
- Publication type:
- Article